HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tae-You Kim Selected Research

Cyclophosphamide (Cytoxan)

12/2017Cyclophosphamide, Methotrexate, and 5-Fluorouracil as Palliative Treatment for Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Retrospective Analysis.
5/2011Concurrent versus sequential administration of CMF chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer.
4/2007Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tae-You Kim Research Topics

Disease

141Neoplasms (Cancer)
01/2024 - 01/2003
53Stomach Neoplasms (Stomach Cancer)
01/2019 - 01/2003
51Breast Neoplasms (Breast Cancer)
07/2023 - 03/2004
43Colorectal Neoplasms (Colorectal Cancer)
12/2023 - 10/2005
30Neoplasm Metastasis (Metastasis)
05/2023 - 04/2004
26Hepatocellular Carcinoma (Hepatoma)
01/2024 - 03/2005
22Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2014 - 06/2002
14Adenocarcinoma
01/2016 - 11/2004
13Colonic Neoplasms (Colon Cancer)
01/2023 - 07/2010
11Rectal Neoplasms (Rectal Cancer)
01/2023 - 12/2013
11Biliary Tract Neoplasms (Biliary Tract Cancer)
10/2017 - 01/2008
10Microsatellite Instability
01/2021 - 07/2011
9Carcinoma (Carcinomatosis)
10/2010 - 02/2004
8Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 10/2011
8Carcinogenesis
12/2017 - 04/2004
7Disease Progression
01/2021 - 01/2008
7Triple Negative Breast Neoplasms
07/2017 - 11/2007
6Nausea
01/2019 - 02/2009
6Lung Neoplasms (Lung Cancer)
01/2015 - 11/2007
6Hypoxia (Hypoxemia)
07/2013 - 02/2002
5Infections
02/2023 - 05/2002
5Vomiting
01/2019 - 12/2004
4Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2018 - 01/2009
3Hepatitis
02/2023 - 07/2014
3Residual Neoplasm
01/2023 - 11/2014
3Fatigue
01/2021 - 10/2014
3Margins of Excision
07/2019 - 12/2013
3Neutropenia
01/2019 - 10/2014
3Obesity
10/2017 - 12/2012
3Thrombocytopenia (Thrombopenia)
07/2016 - 12/2013
3Weight Loss (Weight Reduction)
04/2016 - 06/2002

Drug/Important Bio-Agent (IBA)

28Fluorouracil (Carac)FDA LinkGeneric
12/2023 - 01/2003
21Cisplatin (Platino)FDA LinkGeneric
10/2021 - 11/2002
19DNA (Deoxyribonucleic Acid)IBA
05/2023 - 04/2004
17Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2019 - 05/2008
16Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2011
16Proteins (Proteins, Gene)FDA Link
09/2017 - 01/2003
16ErbB Receptors (EGF Receptor)IBA
10/2015 - 01/2005
15Sorafenib (BAY 43-9006)FDA Link
02/2023 - 04/2011
14Trastuzumab (Herceptin)FDA Link
10/2019 - 01/2008
13Doxorubicin (Adriamycin)FDA LinkGeneric
01/2015 - 12/2003
11GemcitabineFDA Link
10/2021 - 06/2006
11Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 01/2003
11Tyrosine Kinase InhibitorsIBA
07/2018 - 11/2007
11PlatinumIBA
01/2018 - 01/2005
10Leucovorin (Folinic Acid)FDA Link
12/2023 - 05/2008
10Lapatinib (GW572016)FDA Link
10/2019 - 03/2008
10Histone Deacetylase InhibitorsIBA
12/2018 - 03/2004
10Gefitinib (Iressa)FDA Link
02/2012 - 01/2005
9Irinotecan (Camptosar)FDA LinkGeneric
12/2023 - 09/2008
9human ERBB2 proteinIBA
12/2013 - 10/2008
8Hormones (Hormone)IBA
01/2020 - 02/2010
8Estrogen ReceptorsIBA
12/2015 - 03/2004
8Docetaxel (Taxotere)FDA Link
01/2015 - 07/2005
7Cell-Free Nucleic AcidsIBA
02/2024 - 01/2020
7Bevacizumab (Avastin)FDA Link
01/2024 - 02/2013
7Calcibiotic Root Canal SealerIBA
01/2021 - 07/2011
7Capecitabine (Xeloda)FDA Link
03/2019 - 01/2011
7MethyltransferasesIBA
04/2016 - 04/2004
7Histones (Histone)IBA
07/2012 - 08/2005
6Cetuximab (Erbitux)FDA Link
08/2023 - 03/2008
6Circulating Tumor DNAIBA
08/2023 - 01/2020
6regorafenibIBA
07/2023 - 01/2015
6taxaneIBA
12/2017 - 06/2008
5atezolizumabIBA
01/2024 - 01/2020
5Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022 - 09/2009
5NivolumabIBA
11/2020 - 06/2017
5Messenger RNA (mRNA)IBA
10/2019 - 02/2002
5ChromatinIBA
12/2017 - 07/2013
5Thymidylate SynthaseIBA
07/2011 - 12/2006
5Histone Deacetylases (Histone Deacetylase)IBA
08/2010 - 12/2003
5Transforming Growth Factor beta1 (TGF beta 1)IBA
08/2005 - 02/2004
4thiamine triphosphorate (TTP)IBA
01/2018 - 08/2010
4Methotrexate (Mexate)FDA LinkGeneric
12/2017 - 12/2003
4AnthracyclinesIBA
12/2017 - 08/2005
4CytokinesIBA
03/2017 - 12/2007
4hydrogen sulfite (bisulfite)IBA
04/2016 - 04/2004
4Epidermal Growth Factor (EGF)IBA
11/2013 - 11/2006
3olaparibIBA
07/2023 - 06/2013
3RamucirumabIBA
11/2021 - 10/2014
3Monoclonal AntibodiesIBA
01/2021 - 08/2012
3B7-H1 AntigenIBA
01/2021 - 11/2016
3Carcinoembryonic AntigenIBA
01/2020 - 07/2017
3MucinsIBA
07/2019 - 09/2015
3RNA (Ribonucleic Acid)IBA
01/2019 - 10/2007
3HM781-36BIBA
07/2018 - 03/2011
3CohesinsIBA
12/2017 - 01/2016
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2017 - 04/2007
3Phenobarbital (Luminal)FDA Link
01/2016 - 12/2013
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2016 - 12/2008
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2016 - 05/2011

Therapy/Procedure

88Drug Therapy (Chemotherapy)
08/2023 - 11/2002
48Therapeutics
01/2024 - 12/2003
23Neoadjuvant Therapy
01/2023 - 11/2004
19Adjuvant Chemotherapy
01/2023 - 12/2004
19Radiotherapy
04/2022 - 06/2002
15Chemoradiotherapy
02/2024 - 06/2002
12Adjuvant Chemoradiotherapy
04/2017 - 02/2009
12Combination Drug Therapy (Combination Chemotherapy)
09/2014 - 01/2003
3Adjuvant Radiotherapy
01/2016 - 07/2010